Chemours (CC) Operating Income (2016 - 2025)
Chemours (CC) has 12 years of Operating Income data on record, last reported at -$6.0 million in Q4 2025.
- For Q4 2025, Operating Income fell 109.84% year-over-year to -$6.0 million; the TTM value through Dec 2025 reached -$77.0 million, down 124.06%, while the annual FY2025 figure was -$58.0 million, 363.64% down from the prior year.
- Operating Income reached -$6.0 million in Q4 2025 per CC's latest filing, down from $81.0 million in the prior quarter.
- Across five years, Operating Income topped out at $304.0 million in Q1 2022 and bottomed at -$396.0 million in Q2 2023.
- Average Operating Income over 5 years is $72.2 million, with a median of $71.0 million recorded in 2024.
- Peak YoY movement for Operating Income: plummeted 283.33% in 2023, then skyrocketed 1116.67% in 2024.
- A 5-year view of Operating Income shows it stood at $204.0 million in 2021, then plummeted by 104.41% to -$9.0 million in 2022, then surged by 33.33% to -$6.0 million in 2023, then surged by 1116.67% to $61.0 million in 2024, then tumbled by 109.84% to -$6.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Operating Income were -$6.0 million in Q4 2025, $81.0 million in Q3 2025, and -$205.0 million in Q2 2025.